Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | polymerase (DNA directed) iota | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | dna polymerase eta | 0.0023 | 0.1672 | 0.1672 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.1672 | 1 |
Echinococcus multilocularis | dna polymerase kappa | 0.0023 | 0.1672 | 0.1672 |
Loa Loa (eye worm) | intermediate filament protein | 0.003 | 0.2925 | 1 |
Trypanosoma brucei | unspecified product | 0.0023 | 0.1672 | 1 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0023 | 0.1672 | 0.1672 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.1672 | 1 |
Schistosoma mansoni | lamin | 0.003 | 0.2925 | 0.1505 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.1672 | 0.5715 |
Onchocerca volvulus | 0.003 | 0.2925 | 0.5 | |
Echinococcus multilocularis | musashi | 0.003 | 0.2925 | 0.2925 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.1672 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.1672 | 0.5 |
Echinococcus granulosus | dna polymerase kappa | 0.0023 | 0.1672 | 0.1672 |
Brugia malayi | intermediate filament protein | 0.003 | 0.2925 | 1 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.003 | 0.2925 | 1 |
Schistosoma mansoni | intermediate filament proteins | 0.003 | 0.2925 | 0.1505 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.1672 | 0.5 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0023 | 0.1672 | 0.1672 |
Schistosoma mansoni | lamin | 0.003 | 0.2925 | 0.1505 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0023 | 0.1672 | 0.5225 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.1672 | 0.5 |
Echinococcus multilocularis | lamin | 0.003 | 0.2925 | 0.2925 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.2821 | 0.9646 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.1672 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.1672 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.1672 | 1 |
Echinococcus multilocularis | lamin dm0 | 0.003 | 0.2925 | 0.2925 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0023 | 0.1672 | 0.5 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0023 | 0.1672 | 1 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0023 | 0.1672 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.1672 | 1 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.003 | 0.2925 | 1 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0023 | 0.1672 | 0.5 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0023 | 0.1672 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.1672 | 1 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0016 | 0.03 | 0.1026 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0023 | 0.1672 | 0.5715 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0023 | 0.1672 | 0.5225 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.1672 | 1 |
Echinococcus multilocularis | dna polymerase eta | 0.0023 | 0.1672 | 0.1672 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.1672 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.1672 | 1 |
Echinococcus granulosus | lamin | 0.003 | 0.2925 | 0.2925 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.1672 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.2925 | 1 |
Onchocerca volvulus | 0.003 | 0.2925 | 0.5 | |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.1672 | 1 |
Echinococcus granulosus | lamin dm0 | 0.003 | 0.2925 | 0.2925 |
Echinococcus granulosus | intermediate filament protein | 0.003 | 0.2925 | 0.2925 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.1672 | 1 |
Giardia lamblia | DINP protein human, muc B family | 0.0023 | 0.1672 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.6573 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 23.0999 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 29.9349 uM | PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 141.2538 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540273] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.